Monkeypox Vaccine Market

Monkeypox is a viral zoonosis (a virus transmitted to humans from animals) with symptoms very similar to those seen in the past in smallpox patients, although it is clinically less severe. With the eradication of smallpox in 1980 and subsequent cessation of smallpox vaccination, monkeypox has emerged as the most important orthopoxvirus for public health. Monkeypox primarily occurs in Central and West Africa, often in proximity to tropical rainforests and has been increasingly appearing in urban areas. Animal hosts include a range of rodents and non-human primates.
Monkeypox Vaccine Market aims to provide a comprehensive presentation of the global market for Monkeypox Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Monkeypox Vaccine. Monkeypox Vaccine Market contains market size and forecasts of Monkeypox Vaccine in global, including the following market information:
Global Monkeypox Vaccine Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Monkeypox Vaccine Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Monkeypox Vaccine companies in 2022 (%)
The global Monkeypox Vaccine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
DNA Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Monkeypox Vaccine include Bavarian Nordic inks, Emergent BioSolutions and SIGA Technologies, Inc., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Monkeypox Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Monkeypox Vaccine Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Monkeypox Vaccine Market Segment Percentages, by Type, 2022 (%)
DNA
Non-replicating Viral Vector
Protein Subunit
RNA
Others
Global Monkeypox Vaccine Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Monkeypox Vaccine Market Segment Percentages, by Application, 2022 (%)
Aldult
Child
Global Monkeypox Vaccine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Monkeypox Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Monkeypox Vaccine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Monkeypox Vaccine revenues share in global market, 2022 (%)
Key companies Monkeypox Vaccine sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Monkeypox Vaccine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bavarian Nordic inks
Emergent BioSolutions
SIGA Technologies, Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Monkeypox Vaccine, market overview.
Chapter 2: Global Monkeypox Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Monkeypox Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Monkeypox Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Monkeypox Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.